BioStem Technologies Announces Its CEO And COO Each Exercised A Portion Of Their Outstanding Options To Purchase 250K Shares At An Exercise Price Of $2.00/Share, For Total Of 500K Shares At An Aggregate Purchase Price Of ~$1M
Share
Why It Matters
The two top leaders at BioStem each bought company shares using options they already owned. When leaders buy shares, it can show they believe in their company's future.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.